KPCM
AMAG

Kings Point Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Kings Point Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-363
Closed -$11K – 351
2015
Q4 		$11K Buy
+363
New +$11.7K ﹤0.01% 345

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Kings Point Capital Management's AMAG Position: Q1 2016 in Review

Kings Point Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 363 shares — an estimated $11K sold.

Kings Point Capital Management first reported a position in AMAG in Q4 2015 and held it in 1 quarter. The position peaked at $11K in Q4 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Kings Point Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Kings Point Capital Management sold 363 AMAG Pharmaceuticals shares in Q1 2016, an estimated $11K.
  • Kings Point Capital Management first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Kings Point Capital Management's AMAG Pharmaceuticals position peaked at $11K in Q4 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Kings Point Capital Management's 13F filing for Q1 2016, filed 12 May 2016.